BindingDB logo
myBDB logout

21 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28112925 44 Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.EBI University of Tennessee Health Science Center
27774128 38 Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead.EBI ONO Pharmaceutical Co., Ltd.
25746814 80 Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives.EBI Ono Pharmaceutical Co.
25100502 15 Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.EBI The University of Tennessee Health Science Center
25155385 10 Discovery of novel non-carboxylic acid 5-amino-4-cyanopyrazole derivatives as potent and highly selective LPA1R antagonists.EBI Hoffmann-La Roche Inc.
23395664 66 Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.EBI The University of Utah
22894757 69 Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.EBI Hoffmann-La Roche
18178086 26 Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents.EBI Amgen Inc.
20056548 4 Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.EBI University of Tennessee Health Science Center
19800804 19 Structure-based drug design identifies novel LPA3 antagonists.EBI The University of Memphis
18467108 26 Identification of non-lipid LPA3 antagonists by virtual screening.EBI The University of Memphis
17467986 24 Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists.EBI Ajinomoto Company Inc.
16913720 15 Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.EBI The University of Utah
16263282 43 Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.EBI University of Tennessee Health Science Center
16033271 81 Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.EBI University of Tennessee Health Science Center
15225728 55 A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist.EBI University of Virginia
15177455 27 Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.EBI Oxford University
15125924 63 Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.EBI University of Virginia